# Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

> **NCT01999725** · PHASE1 · COMPLETED · sponsor: **Enanta Pharmaceuticals, Inc** · enrollment: 80 (actual)

## Conditions studied

- Safety in Normal Volunteers

## Interventions

- **DRUG:** EDP-788
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01999725
- **Lead sponsor:** Enanta Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999725, "Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01999725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*